Aurigon is a contract research organization that provides comprehensive preclinical services for human and veterinary pharmaceuticals, food, and chemicals. Established in 2000, the company specializes in offering advisory and experimental services in pharmacology, bio-analytics, and toxicology. Their services cover early-phase product efficacy and safety evaluations to regulatory toxicology and late-stage pre-marketing testing.
The company's slogan "Providing comprehensive preclinical services for pharmaceuticals, food, and chemicals, from early-phase evaluation to late-stage testing" encapsulates their commitment to catering to the needs of the Health Care and Pharmaceutical industries.
Although specific information regarding its headquarters and recent investments is not available, Aurigon's focus on preclinical services for a wide range of sectors positions it as an attractive prospect for investors looking to tap into the growing demands for pharmaceutical and chemical testing services.